Coronavirus Success Stories
Coronavirus survivors talk about their symptoms, recovery
April 6 - Trump said 3M agreed to provide 55.5 million masks a month for the U.S. for three months. Most of them will be the highly coveted N95 respirators that filter out 95% of all particulates.
April 10 - Gilead Has Treated More Than 1,700 COVID-19 Patients With Remdesivir
The drug remdesivir is being studied in people with COVID-19. It works by stopping the coronavirus from making copies of itself. The FDA is now allowing remdesivir to be used in adults and children hospitalized with COVID-19 disease, as it may shorten the recovery time in some people. Side effects of remdesivir can include abnormal liver tests and reactions when the drug is given, such as low blood pressure, sweating and chills. Studies are still going on to learn more about how safe and effective remdesivir is in treating COVID-19.
Two-Thirds of Severe Covid-19 Cases Improved on Gilead Drug
April 11 - STIMULUS CHECKS FOR UP TO $4,700 BEGIN ARRIVING IN BANK ACCOUNTS
US States reopen coronavirus (April 15)
Some Countries Have Brought New Cases Down To Nearly Zero. How Did They Do It?
Coronavirus Success Stories New Zealand
June 29, 2020 - Trump Administration Secures New Supplies of Remdesivir for the United States - HHS has secured more than 500,000 treatment courses of the drug for American hospitals through September.
August 7, 2020 - The Top 5 COVID-19 Vaccine Candidates Explained
August 20, 2020 - Regeneron Boosts Production Capacity for COVID-19 Antibody Cocktail - quadruple production
September 29, 2020 - REGENERON'S REGN-COV2 ANTIBODY COCKTAIL REDUCED VIRAL LEVELS AND IMPROVED SYMPTOMS IN NON-HOSPITALIZED COVID-19 PATIENTS
October 1, 2020 - Veklury (remdesivir) Now Available Directly from Distributor following Trump Administration’s Successful Allocations to States and U.S. Territories
October 5, 2020 - Here are the most promising coronavirus vaccine candidates out there
October 17, 2020 - California readies its COVID-19 vaccine distribution plan
California has prepared an unprecedented vaccination campaign against the COVID-19 virus, to protect 40 million residents from the deadly disease. Virginia and Colorado turned in their plans earlier this week.
The frontrunner vaccine, made by Pfizer, may demand a lot of special refrigerators that are only available at academic research centers. This vaccine can’t be stored in the refrigeration systems found at the typical doctor’s office. Instead, it requires special ultra-low-temperature freezers that can store medicine at minus-328 degrees Fahrenheit. It also requires a booster shot, further complicating its rollout.
October 17, 2020 - CDC COVID-19 Vaccination Program
October 18, 2020 - Virginia, Maryland, DC, other states to submit Coronavirus vaccine blueprints
October 18, 2020 - MONTGOMERY COUNTY WORKING WITH STATE ON COVID-19 VACCINE DISTRIBUTION PLAN
October 18, 2020 - Virginia begins planning for eventual COVID-19 vaccine
October 18, 2020 - RI and Massachusetts release COVID-19 vaccination plans
October 18, 2020 - Colorado Announces Its COVID-19 Vaccine Distribution Plan
October 18, 2020 - NC, SC ON HOW THEY WILL DISTRIBUTE COVID-19 VACCINE
October 18, 2020 - Kentucky will distribute COVID-19 vaccine
October 18, 2020 - MISSOURI HAS SUBMITTED COVID-19 VACCINE PLAN
October 18, 2020 - CT Coronavirus Vaccine Plan
October 18, 2020 - New York COVID-19 vaccination plan
October 18, 2020 - Texas COVID-19 VACCINE Plan
October 18, 2020 - Massachusetts releases COVID-19 vaccination plan
October 18, 2020 - Maine submits plan distributing COVID-19 vaccination plan
October 18, 2020 - W.Va completes COVID-19 vaccine action plan
October 18, 2020 - RI prepares for COVID-19 vaccination plan
October 18, 2020 - Hawaii’s COVID-19 Vaccination Plan
October 18, 2020 - Minnesota plans for COVID-19 vaccine distribution
October 18, 2020 - Utah plans Coronavirus Vaccination Plan
October 18, 2020 - Ohio already preparing COVID-19 vaccine plans
October 19, 2020 - States Rush to Get COVID-19 Vaccination Plans to CDC
October 19, 2020 - SARS-CoV-2 vaccine Leading COVID-19 vaccine candidates have progressed through laboratory tests at record speed.
October 19, 2020 - For Trump, Covid-19 therapeutics are the new vaccines
October 19, 2020 - Johns Hopkins Scientists Discover Possible Key to Controlling COVID-19 Immune Response
October 19, 2020 - UNICEF To Stockpile Over Half A Billion Syringes For Future COVID-19 Vaccine
October 21, 2020 - WASHINGTON STATE ANNOUNCES 'INTERIM' CORONAVIRUS VACCINE DISTRIBUTION PLAN
October 21, 2020 - Utah unveils COVID-19 vaccination plan
October 21, 2020 - Tennessee Dept. of Health releases COVID-19 vaccine distribution plan
October 21, 2020 - New studies suggest there has been a 'sharp' drop in COVID-19 death rates
October 21, 2020 - Study helps explain declines in death rates from COVID-19